Table 1.
Baseline characteristics of patients and healthy subjects
| Variable | Patients (N = 11) | Healthy subjects (N = 10) |
|---|---|---|
| Age (years) | 51·3 ± 13·5 (24–66) | 50·2 ± 12·5 (28–64) |
| Sex, N (%) | ||
| Female | 3 (27) | 3 (30) |
| Male | 8 (73) | 7 (70) |
| Race, N (%) | ||
| White | 11 (100) | 10 (100) |
| Height (cm) | 176·5 ± 7·0 (163–189) | 172·5 ± 6·8 (162–182) |
| Weight (kg) | 77·5 ± 8·3 (62·2–92·1) | 78·3 ± 7·5 (63·5–90·8) |
| BMI (kg/m2) | 25·0 ± 3·2 (20·3–29·2) | 26·3 ± 1·8 (22·8–28·8) |
| Time in present HD treatment (years) | 2·1 ± 2·2* (0·3–6·7) | N/A |
| Kt/V | 1·4 ± 0·3 (1·2–2·1) | N/A |
| Systolic blood pressure | 127·7 ± 34·0 | 129·5 ± 10·3 |
| Diastolic blood pressure | 80·2 ± 9·3 | 81·3 ± 7·6 |
| Fasting plasma glucose (mmol/l) | 4·6 ± 0·5 | 4·8 ± 0·5 |
Values are the mean ± SD (range), except for sex and race, N(%).
*
Based on 10 patients.
BMI, body mass index; HD, haemodialysis; N/A: not applicable.